In people, no one knows, because no study has measured Dihexa’s effects on the human brain. In animals and cell cultures, the research describes three main actions.
First, it is an analog of angiotensin IV, a brain peptide that improved memory and learning in rats when injected into the brain (PMID 33178027). A 2008 review describes angiotensin IV as enhancing acquisition, consolidation and recall in animal models of learning and memory (PMID 19090988). A 2020 review traces how that work led to small molecules that inhibit insulin-regulated aminopeptidase, the binding site also called the AT4 receptor (PMID 33178027).
Second, Dihexa appears to act through hepatocyte growth factor and its receptor c-Met. In hippocampal neuron cultures it increased dendritic spine density, a proxy for synaptic connections (Benoist et al., 2011), and in cultures lacking HGF it had no effect (McCoy et al., 2013). Third, it was built to cross the blood-brain barrier.
Treated rats did better in maze and amnesia tests, which are lab screens. Whether any of this happens in a human brain is unmeasured. A licensed clinician can walk you through options with human evidence behind them.